期刊文献+

75岁以上ST段抬高心肌梗死患者再灌注治疗进展 被引量:8

下载PDF
导出
摘要 急性心肌梗死(AMI)是65岁以上老年人高病死率的主要病因之一。Sugiura等通过尸体解剖发现,60岁以上的人群冠心病患病率超过50%,且大部分是左主干甚至是3支病变。GRACE及CRUSADE研究发现,75岁以上急性冠状动脉脉综合征患者占总研究人群的三分之一左右。再灌注治疗可显著降低ST段抬高心肌梗死(STEMI)患者的病死率,改善临床预后。
出处 《中华老年心脑血管病杂志》 CAS 2015年第4期436-437,共2页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
  • 相关文献

参考文献11

  • 1Carro A,Kaski JC. Myocardial infarction in the elderly. Aging Dis,2011,2:116 -137.
  • 2Nguyen HI.,Saczynski JS,Gore JM,et al. Age and sex differ ences in duration of pre hospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outeomes, 2010,3 : 82-92.
  • 3Task Force on the management of ST segment elevation acute myocardial infaretion of the European Society of Cardiology (ESC), Steg PG, James SIC, et al. ESC Guidelines for the management of acute myocardial infarction in patients presen ting with STsegment elevation. Eur Heart J,2012,33:2569 2619.
  • 4China Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Guideline for diagnosis and treatment of patients with ST elevation my- ocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi, 2010,38 : 675-690.
  • 5Danzi GB,Centola M,Pomidossi GA,et al. Usefulness of pri- mary angloplasty in nonagenarians with acute myocardial in- farction. Am J Cardiol, 2010,106 : 770-773.
  • 6Velders MA,James SK, 1.ibungan B,et al. Prognosis of elder- ly patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011:A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry. Am Heart J, 2014, 167:666-673.
  • 7Rodriguez-Leor O, Fernandez-Nofrerias E, Carrillo X, et al. Results of primary percutaneous coronary intervention in pa- tients 75 years treated by the transradial approach. Am J Cardiol, 2014,113: 452-456.
  • 8Khera S, Kolte D, Palaniswamy C, et al. ST-elevation myocar dial infarction in the elderly -temporal trends in incidence,uti- lization of percutaneous coronary intervention and outcomes in the United States. Int J Cardiol, 2013,168 : 3683-3690.
  • 9Park KH,Jeong MH, Lee KH, et al. Comparison of peri-pro- cedural platelet inhibition with prasugrel versus adjunctive eilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction. J Cardiol, 2014,63 : 99 -105.
  • 10Lipinski MJ, Lhermusier T, Esearcega RO, et al. Bivalirudin versus heparin for percutaneous coronary intervention:an up- dated meta-analysis of randomized controlled trials. Cardio- vasc Revasc Med, 2014,15 : 315-322.

同被引文献71

  • 1刘大一,王智昊.替格瑞洛在老年ST段抬高型心肌梗死患者急诊冠状动脉介入治疗中的应用[J].中国老年学杂志,2014,34(10):2638-2641. 被引量:21
  • 2张军芳,王磊,魏聪,王宏涛,常丽萍.慢性心力衰竭能量代谢重构与治疗进展[J].中国老年学杂志,2014,34(4):1115-1117. 被引量:19
  • 3韩雅玲,邓捷,荆全民,王守力,马颖艳,栾波.急性心肌梗死急诊介入治疗无再流发生的独立预测因素及对长期预后的影响[J].中华心血管病杂志,2006,34(6):483-486. 被引量:52
  • 4Su Q, Nyi TS, Li L. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in peoplewith acute myocardial infarction. Cochrane Database Syst Rev, 2015,5 : CD009503.
  • 5Zhou SS, Tian F, Chen YD, et al. Combination therapy re- duces the incidence of no-reflow after primary percutaneons coronary intervention in patients with ST-segment elevation acute myocardial infarction. J Geriatr Cardiol, 2015,12:135 142.
  • 6Akpek M, Sahin O, Sarli B, et al. Acute Effects of Intracoro- nary tirofiban on no-reflow phenomena in patients with ST- segment elevated myocardial infarction undergoing primary percutaneous coronary intervention. Angiology, 2015,66 : 560- 567.
  • 7Huang D,Qian J,Ge L,et al. REtoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocardial infarction (RECOVER). Am Heart J, 2012,164:394-401.
  • 8Prati F, Di Vito L, Ramazzotti V, et al. Randomized trial of standard versus ClearWay-infused abciximab and thrombecto my in myocardial infarction: rationale and design of the COCTAIL 1] study. J Cardiovasc Med (Hagerstown), 2013, 14 : 364-371.
  • 9Carrick D, Oldroyd KG, McEntegart M, et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST segment elevation myocardial infarction (DEFER-STEMI). J Am Coil Cardiol, 2014, 63 : 2088-2098.
  • 10Durante A,Camici PG. Novel insights into an "old" phenome- non: the no reflow. Int J Cardiol, 2015,187 : 273-280.

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部